Growth Metrics

Pacific Biosciences Of California (PACB) Restructuring Costs (2021 - 2023)

Pacific Biosciences Of California has reported Restructuring Costs over the past 2 years, most recently at $63000.0 for Q4 2023.

  • For Q4 2023, Restructuring Costs changed N/A year-over-year to $63000.0; the TTM value through Dec 2024 reached $9.0 million, changed N/A, while the annual FY2023 figure was $9.0 million, N/A changed from the prior year.
  • Restructuring Costs for Q4 2023 was $63000.0 at Pacific Biosciences Of California, down from $9.0 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $12.0 million in Q3 2021 and troughed at $63000.0 in Q4 2023.